.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Federal Trade Commission
Chinese Patent Office
UBS
Fish and Richardson
Colorcon
Accenture
Healthtrust
Covington

Generated: September 23, 2017

DrugPatentWatch Database Preview

Lithium carbonate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lithium carbonate and what is the scope of lithium carbonate patent protection?

Lithium carbonate
is the generic ingredient in seven branded drugs marketed by Hetero Labs Ltd Iii, Watson Labs, West-ward Pharms Int, Hikma Intl Pharms, Glenmark Generics, Mylan Pharms Inc, Able, Ani Pharms Inc, Sun Pharm Inds Inc, Heritage Pharma, Bayer Pharms, Pfizer, Usl Pharma, Glenmark Pharms Inc, Alembic Pharms Ltd, Jds Pharms, Alembic Ltd, Noven Therap, Unique Pharm Labs, Barr, Solvay, and Apotex Inc, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for lithium carbonate. Thirty-four suppliers are listed for this compound.

Summary for Generic Name: lithium carbonate

Tradenames:7
Patents:0
Applicants:22
NDAs:36
Drug Master File Entries: see list15
Suppliers / Packagers: see list34
Bulk Api Vendors: see list55
Clinical Trials: see list405
Patent Applications: see list80
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:lithium carbonate at DailyMed

Pharmacology for Ingredient: lithium carbonate

Drug ClassMood Stabilizer
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics
LITHIUM CARBONATE
lithium carbonate
CAPSULE;ORAL079139-001Feb 3, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Pfizer
LITHIUM CARBONATE
lithium carbonate
TABLET;ORAL016834-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd Iii
LITHIUM CARBONATE
lithium carbonate
CAPSULE;ORAL090702-002Sep 25, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
LITHIUM CARBONATE
lithium carbonate
TABLET;ORAL018558-001Jan 29, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Jds Pharms
ESKALITH
lithium carbonate
TABLET;ORAL017971-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
LITHIUM CARBONATE
lithium carbonate
CAPSULE;ORAL076243-002Feb 24, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharma
LITHIUM CARBONATE
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL205532-001Sep 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Solvay
LITHONATE
lithium carbonate
CAPSULE;ORAL016782-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Barr
LITHIUM CARBONATE
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL076170-001Jun 10, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
LITHIUM CARBONATE
lithium carbonate
CAPSULE;ORAL017812-002Jan 28, 1987ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lithium carbonate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc
LITHOBID
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL018027-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Cerilliant
Covington
McKinsey
US Department of Justice
Colorcon
McKesson
Baxter
Deloitte
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot